Mihayluk E. «Pharmacological activity of new derivatives of 4-R-5-(alkyl-, aryl-, heteryl-)-1,2,4-triazole under experimental toxic hepatitis »

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0415U005896

Applicant for

Specialization

  • 14.03.05 - Фармакологія

15-10-2015

Specialized Academic Board

Д 64.605.03

National University of Pharmacy

Essay

The thesis of Mikhailuk E.O. is devoted to the study of hepatoprotective action of the 4-R-5 (alkyl-, aryl-, heteryl -) - 1,2,4-triazole in toxic hepatitis and studying the pharmacological activity of the specific compound leader (4-amino-5-(furan-2 yl)-4H-1,2,4-triazole-3-thiol), which has shown itself to be the most effective and safe substance. The parameters acute toxicity of novel derivatives of 4-R-5- (alkyl-, aryl-, heteryl-) - 1,2,4-triazole with intragastric administration and found that the LD50 of the test compounds in the range 668-2430 mg / kg of substance and belong to the IV class toxicity of classification K.K. Sidorov (1973). Among the derivatives of 1,2,4-triazole selected most active ingredient 4-amino-5-(furan-2-yl)-4H-1,2,4-triazole-3-thiol (part number 2.8), which was recommended for future preclinical trials. New scientific data on the specific pharmacological activity of the compound 2.8 in acute and subacute experimental hepatitis.

Files

Similar theses